This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Pain, Neuropathic Pain or Cancer
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to determine if Oxymorphone Extended Release is effective and safe in treating chronic pain in patients with cancer or neuropathic pain.

Provided treatments

  • Drug: Oxymorphone Extended Release
Tris trial is registered with FDA with number: NCT00911261. The sponsor of the trial is Endo Pharmaceuticals and it is looking for 223 volunteers for the current phase.
Official trial title:
An Open-Label Long Term Effectiveness and Safety Study of Oxymorphone Extended Release Tablets in Patients With Cancer or Neuropathic Pain